GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » PS Ratio

RIV Capital (XCNQ:RIV) PS Ratio : 1.93 (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, RIV Capital's share price is C$0.145. RIV Capital's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.08. Hence, RIV Capital's PS Ratio for today is 1.93.

The historical rank and industry rank for RIV Capital's PS Ratio or its related term are showing as below:

XCNQ:RIV' s PS Ratio Range Over the Past 10 Years
Min: 1.27   Med: 19.13   Max: 1425
Current: 1.93

During the past 5 years, RIV Capital's highest PS Ratio was 1425.00. The lowest was 1.27. And the median was 19.13.

XCNQ:RIV's PS Ratio is ranked better than
52.75% of 999 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs XCNQ:RIV: 1.93

RIV Capital's Revenue per Sharefor the three months ended in Mar. 2024 was C$0.02. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.08.

During the past 12 months, the average Revenue per Share Growth Rate of RIV Capital was 33.90% per year.

Back to Basics: PS Ratio


RIV Capital PS Ratio Historical Data

The historical data trend for RIV Capital's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital PS Ratio Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
PS Ratio
- 150.40 15.00 34.26 -

RIV Capital Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.14 1.85 2.81 1.52 1.20

Competitive Comparison of RIV Capital's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's PS Ratio distribution charts can be found below:

* The bar in red indicates where RIV Capital's PS Ratio falls into.



RIV Capital PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

RIV Capital's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.145/0.075
=1.93

RIV Capital's Share Price of today is C$0.145.
RIV Capital's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


RIV Capital  (XCNQ:RIV) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


RIV Capital PS Ratio Related Terms

Thank you for viewing the detailed overview of RIV Capital's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.
Executives
Richard P. Mavrinac Director
Edward James Cirillo Lucarelli Senior Officer